
Sign up to save your podcasts
Or
Summary
Dr Gideon Hirschfield is a leading expert in autoimmune liver diseases, including PSC, PBC, and autoimmune hepatitis. He’s helped shape how these conditions are understood and managed around the world, combining cutting-edge research with a real passion for patient care.
Today he discusses his work with autoimmune liver diseases, particularly primary sclerosing cholangitis (PSC) and autoimmune hepatitis. We discuss some key topics in PSC (including use of Ursodeoxycholic acid, cancer surveillance as well as the PSC/IBD phenotype), and Professor Hirschfield gives us a masterclass in the management of autoimmune hepatitis. He also offers advice for new hepatologists, highlighting the significance of clear diagnoses, individualized patient management, and clinical trials to drive us into the future.
As always comments, questions and feedback please send to: X: @2guystalkingit
Email: [email protected]
Chapters
00:30 J & J Introduction
06:15 Introduction to Professor Hirschfield and Autoimmune Liver Diseases
07:41 The Role of Ursodeoxycholic Acid in PSC Management
19:06 Understanding the Pathophysiology of PSC
22:43 Cancer Surveillance in PSC Patients
28:39 The Relationship Between PSC and Inflammatory Bowel Disease
32:30 Vancomycin and PSC
36:28 Management Strategies for PSC and IBD Patients including Pouches
40:00 Management of Autoimmune Hepatitis: An Art and Science
56:30 Proactive Approaches in Primary Biliary Cholangitis (PBC) Management
1:01:05 Advice for Aspiring Hepatologists
Keywords
Hepatology, Autoimmune Liver Disease, PSC, Ursodeoxycholic Acid, Cancer Surveillance, Inflammatory Bowel Disease, Clinical Trials, Patient Care, Liver Transplantation, PSC Management, pouch studies, autoimmune hepatitis, management, PBC, hepatology, patient choices, liver transplant, treatment options, chronic diseases, clinical trials
5
44 ratings
Summary
Dr Gideon Hirschfield is a leading expert in autoimmune liver diseases, including PSC, PBC, and autoimmune hepatitis. He’s helped shape how these conditions are understood and managed around the world, combining cutting-edge research with a real passion for patient care.
Today he discusses his work with autoimmune liver diseases, particularly primary sclerosing cholangitis (PSC) and autoimmune hepatitis. We discuss some key topics in PSC (including use of Ursodeoxycholic acid, cancer surveillance as well as the PSC/IBD phenotype), and Professor Hirschfield gives us a masterclass in the management of autoimmune hepatitis. He also offers advice for new hepatologists, highlighting the significance of clear diagnoses, individualized patient management, and clinical trials to drive us into the future.
As always comments, questions and feedback please send to: X: @2guystalkingit
Email: [email protected]
Chapters
00:30 J & J Introduction
06:15 Introduction to Professor Hirschfield and Autoimmune Liver Diseases
07:41 The Role of Ursodeoxycholic Acid in PSC Management
19:06 Understanding the Pathophysiology of PSC
22:43 Cancer Surveillance in PSC Patients
28:39 The Relationship Between PSC and Inflammatory Bowel Disease
32:30 Vancomycin and PSC
36:28 Management Strategies for PSC and IBD Patients including Pouches
40:00 Management of Autoimmune Hepatitis: An Art and Science
56:30 Proactive Approaches in Primary Biliary Cholangitis (PBC) Management
1:01:05 Advice for Aspiring Hepatologists
Keywords
Hepatology, Autoimmune Liver Disease, PSC, Ursodeoxycholic Acid, Cancer Surveillance, Inflammatory Bowel Disease, Clinical Trials, Patient Care, Liver Transplantation, PSC Management, pouch studies, autoimmune hepatitis, management, PBC, hepatology, patient choices, liver transplant, treatment options, chronic diseases, clinical trials
71 Listeners
3,333 Listeners
1,111 Listeners
799 Listeners
53 Listeners
195 Listeners
282 Listeners
3,100 Listeners
0 Listeners
939 Listeners
11 Listeners
236 Listeners
882 Listeners
444 Listeners
838 Listeners